Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure

BACKGROUND: Young women treated with chest radiation therapy (RT) for Hodgkin lymphoma (HL) experience a strongly increased risk of breast cancer (BC). It is unknown whether endogenous and exogenous gonadal hormones affect RT-associated BC risk. METHODS: We conducted a nested case-control study among female 5-year HL survivors treated before age 41. Hormone exposure and HL treatment data were collected through medical records and questionnaires for 174 BC case patients and 466 control patients. Radiation dose to breast tumor location was estimated based on RT charts, simulation films, and mamm... Mehr ...

Verfasser: Krul, Inge M
Opstal-van Winden, Annemieke W J
Aleman, Berthe M P
Janus, Cécile P M
van Eggermond, Anna M
De Bruin, Marie L
Hauptmann, Michael
Krol, Augustinus D G
Schaapveld, Michael
Broeks, Annegien
Kooijman, Karen R
Fase, Sandra
Lybeert, Marnix L
Zijlstra, Josée M
van der Maazen, Richard W M
Kesminiene, Ausrele
Diallo, Ibrahima
de Vathaire, Florent
Russell, Nicola S
van Leeuwen, Flora E
Dokumenttyp: Artikel
Erscheinungsdatum: 2017
Schlagwörter: Adult / Antineoplastic Agents / Alkylating / Breast / Breast Neoplasms / Carcinoma / Intraductal / Noninfiltrating / Case-Control Studies / Confidence Intervals / Dose-Response Relationship / Radiation / Female / Gonadal Steroid Hormones / Hodgkin Disease / Hormone Replacement Therapy / Humans / Menopause / Premature / Middle Aged / Neoplasms / Radiation-Induced / Netherlands / Ovary / Procarbazine / Radiotherapy Dosage / Risk Factors / Survivors / Time Factors / Young Adult / Journal Article / Taverne
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29202014
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dspace.library.uu.nl/handle/1874/361848